Jan Vosshenrich,Elmar M Merkle,Tobias Heye
Jan Vosshenrich
Purpose of review: This review aims to highlight the often-overlooked environmental impact of medical imaging in urological practice, focusing on energy consumption, associated carbon emissions, and practical strategies f...
Climate change and urologic care: a challenge for patients and providers [0.03%]
气候变化与泌尿科护理：患者和医务人员面临的挑战
Pietro Brin,Klara Pohl,Alexander P Cole
Pietro Brin
Purpose of review: This review examines the interplay between environmental changes and urology. While there is widespread recognition of the large impacts of climate change on population health, there are specific ways i...
Antibody-drug conjugates for non-muscle invasive bladder cancer: current status and future development [0.03%]
抗体偶联药物在非肌层浸润性膀胱尿路上皮癌中的应用现状及未来展望
Francesco M Bracco,Chris H M Wong,Jeremy Y C Teoh
Francesco M Bracco
Purpose of review: Antibody-drug conjugates (ADCs) have recently emerged as a promising targeted therapeutic strategy in urothelial carcinoma, and their application in nonmuscle invasive bladder cancer (NMIBC) is an evolv...
Hyperthermic intravesical chemotherapy for Bacillus Calmette-Guérin-unresponsive nonmuscle-invasive bladder cancer [0.03%]
卡介菌减毒疫苗治疗无效的非肌层浸润性膀胱癌的热化体内化疗
Félix Guerrero-Ramos,Carmen Gómez-Cañizo,Mario Hernández-Arroyo et al.
Félix Guerrero-Ramos et al.
Purpose of review: Hyperthermic intravesical chemotherapy (HIVEC) and other device-assisted platforms are emerging bladder-sparing options after Bacillus Calmette-Guérin (BCG) failure in nonmuscle-invasive bladder cancer...
Carbon ion radiotherapy as a dose escalation tool in the treatment of primary high-risk prostate cancer [0.03%]
碳离子放疗在高危前列腺癌治疗中的剂量递增作用研究
Matthias Moll,Piero Fossati,Carola Lütgendorf-Caucig et al.
Matthias Moll et al.
Purpose of review: Prostate cancer is the most common cancer in men. In the high-risk group, carbon ion radiotherapy (CIRT) is being developed as a state-of-the-art alternative for treatment. ...
Artificial intelligence in muscle-invasive bladder cancer: opportunities, challenges, and clinical impact [0.03%]
人工智能在肌层浸润性膀胱癌中的应用：机遇、挑战及临床影响
Federico Mastroleo,Giulia Marvaso,Barbara Alicja Jereczek-Fossa
Federico Mastroleo
Purpose of review: Muscle-invasive bladder cancer (MIBC) represents an aggressive malignancy with significant morbidity and mortality. Recent advances in artificial intelligence (AI) offer promising opportunities to enhan...
Marcin Miszczyk
Marcin Miszczyk
Biochemical recurrence in prostate cancer - toward precision in definition, diagnosis, and management [0.03%]
前列腺癌生化复发——定义、诊断和治疗的精准医学方向
Tobias Maurer,Fabian Falkenbach
Tobias Maurer
VISION, TheraP, LuTectomy and beyond - is there a role for lutetium therapy in biochemical recurrence? [0.03%]
VISIOM、TheraP、LuTectomy等之后还有镥治疗生化复发的一席之地吗？
David Hennes,Jasmin Weindler,Christa Babst et al.
David Hennes et al.
Purpose of review: This review synthesizes current evidence and recommendations for the use of lutetium-177 prostate-specific membrane antigen (LuPSMA) radioligand therapy across the spectrum of prostate cancer, focusing ...